Molecular and Digital Medicine is a pioneering, multidisciplinary, open-access journal dedicated to advancing research at the dynamic convergence of molecular biology, digital technologies, and biomedical engineering. The journal aims to publish high-quality, peer-reviewed research that explores the innovative integration of molecular science with digital health tools and engineering solutions, with the ultimate goal of revolutionizing personalized medicine, diagnostics, and therapeutic interventions.

Our scope encompasses the full spectrum of research at this pivotal intersection. This includes foundational and applied research in Molecular and Nanoscale Medicine, such as molecular diagnostics, biomarkers, omics sciences, precision medicine, nanomedicine, gene editing, and biomaterials. A core focus is also on Digital Health Technologies, including artificial intelligence (AI) and machine learning, digital therapeutics, wearable devices, biosensors, and health informatics.

A distinctive priority is the Integration and Convergence of these fields, covering areas like digital biomarkers, AI-driven multi-omics analysis, engineered diagnostic devices, smart theranostic platforms, and digital tools for clinical trials. The journal strongly emphasizes Clinical Applications and Translational Medicine, welcoming work that bridges these discoveries into clinical practice, develops personalized strategies and devices, and addresses the associated ethical, regulatory, and security challenges.

Molecular and Digital Medicine seeks to foster essential collaborations across disciplines, including molecular biology, bioinformatics, clinical medicine, biomedical engineering, and digital health, to catalyse the development of innovative, end-to-end solutions that improve patient care, healthcare delivery, and global health outcomes.

Editorial Board